Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FS2 for prevention of scarring in skin grafts and donor sites
NCT04186273Phase 2Unknown
- Sponsor
- University of British Columbia
- Start
- Dec 2019
- Primary completion
- Feb 2021
- Countries
- 1
01
Overview
A Phase 2 trial of Kynurenic acid in Hypertrophic Scar (HS), keloid, skin graft scarring (not an official disease; best represented as “scarring after skin graft” or “post-skin graft scar”), sponsored by University of British Columbia. Status: unknown.
02
Drugs
Kynurenic acid
03
Conditions
Hypertrophic Scar (HS)keloidskin graft scarring (not an official disease; best represented as “scarring after skin graft” or “post-skin graft scar”)
Beyond the preview
Go deeper on NCT04186273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04186273.